Literature DB >> 17852780

Epidermal growth factor levels are related to diastolic blood pressure and carotid artery stiffness.

Ulf Lundstam1, Ulrika Hägg, Yrsa Bergmann Sverrisdottir, Lennart E T Svensson, Li-ming Gan.   

Abstract

OBJECTIVES: The epidermal growth factor (EGF) is believed to be involved in vascular remodelling. EGF receptors are expressed in human atherosclerotic tissue.
DESIGN: In order to study the role of EGF in vascular remodelling and early progression of atherosclerosis, 17 men and 16 women aged 20 to 45 years were recruited. Common Carotid Artery Stiffness index (CCA SI) and blood pressure were evaluated. In addition, serum levels of EGF and blood lipids were measured.
RESULTS: The levels of serum EGF were significantly correlated to diastolic blood pressure (p<0.05) and CCA SI (p<0.05). Subjects with EGF concentrations in the upper median had significantly lower levels of HDL (High Density Lipoproteins) (p<0.05) and ApoA1 (Apolipoprotein) (p<0.05) than those with EGF concentrations in the lower median. DISCUSSION: High serum level of EGF is associated with elevated diastolic blood pressure and increased vessel stiffness suggesting a possible functional role of EGF in the cardiovascular system in a healthy population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17852780     DOI: 10.1080/14017430701439508

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  3 in total

Review 1.  The roles of integrins in mediating the effects of mechanical force and growth factors on blood vessels in hypertension.

Authors:  Jun-Tzu Chao; Michael J Davis
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

2.  Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System.

Authors:  Steven J Forrester; Tatsuo Kawai; Shannon O'Brien; Walter Thomas; Raymond C Harris; Satoru Eguchi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-11-09       Impact factor: 13.820

3.  Ticagrelor Improves Endothelial Function by Decreasing Circulating Epidermal Growth Factor (EGF).

Authors:  Francesco Vieceli Dalla Sega; Francesca Fortini; Giorgio Aquila; Rita Pavasini; Simone Biscaglia; Davide Bernucci; Annamaria Del Franco; Elisabetta Tonet; Paola Rizzo; Roberto Ferrari; Gianluca Campo
Journal:  Front Physiol       Date:  2018-04-06       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.